RSCM
XLO icon

Rock Springs Capital Management’s Xilio Therapeutics XLO Stock Holding History

Rock Springs Capital Management’s Portfolio XLO Stock Details XLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-214,519
Closed -$2.87M – 109
2024
Q4 		$2.87M Hold
214,519
– – 0.11% 88
2024
Q3 		$2.37M Hold
214,519
– – 0.08% 94
2024
Q2 		$2.85M Buy
214,519
+111,608
+108% +$1.75M 0.09% 97
2024
Q1 		$1.56M Hold
102,911
– – 0.04% 110
2023
Q4 		$792K Hold
102,911
– – 0.02% 101
2023
Q3 		$3.04M Hold
102,911
– – 0.08% 92
2023
Q2 		$3.77M Hold
102,911
– – 0.09% 94
2023
Q1 		$4.57M Buy
102,911
+5,563
+6% +$244K 0.11% 91
2022
Q4 		$3.67M Hold
97,348
– – 0.09% 95
2022
Q3 		$3.97M Hold
97,348
– – 0.1% 99
2022
Q2 		$3.98M Buy
97,348
+12,270
+14% +$649K 0.12% 101
2022
Q1 		$8.42M Hold
85,078
– – 0.21% 88
2021
Q4 		$19.1M Buy
+85,078
New +$20.3M 0.44% 66

Other funds holding XLO

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return